126 results
8-K
EX-99.1
BSGM
Biosig Technologies Inc
30 May 24
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:26pm
) the geographic, social, and economic impact of pandemics or worldwide health issues on BioSig’s ability to conduct its business and raise capital in the future
8-K
EX-99.1
BSGM
Biosig Technologies Inc
30 May 24
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:26pm
by 50%; (iii) the geographic, social, and economic impact of pandemics or worldwide health issues on BioSig’s ability to conduct its business
8-K
BSGM
Biosig Technologies Inc
30 May 24
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:26pm
by 50%; (iii) the geographic, social, and economic impact of pandemics or worldwide health issues on the Company’s ability to conduct its business
8-K
EX-99.1
BSGM
Biosig Technologies Inc
3 May 24
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
8:30am
measures not reaching the targeted reduction of cash burn by 50%; (iii) the geographic, social, and economic impact of pandemics or worldwide health issues
8-K
EX-4.1
BSGM
Biosig Technologies Inc
12 Mar 24
Entry into a Material Definitive Agreement
9:38am
)
Signature
Name of Entity
Print Name
Signature
Print Name:
Title:
Address of Principal Residence:
Address of Executive Offices:
Social Security
8-K
EX-99.1
98n71
6 Feb 24
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
8:35am
8-K
EX-99.1
0wlxs7t703z3a1dz eqf
31 Jan 24
BioSig Announces Reverse Stock Split
4:05pm
8-K
EX-99.1
4mfvic3r 4h
30 Jan 24
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
8:52am
8-K
EX-99.1
nf222
6 Dec 23
Regulation FD Disclosure
5:07pm
8-K
EX-99.1
7bp5d ax8kt1kf46xz0
13 Nov 23
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:02pm
8-K
EX-99.1
0jouib
13 Nov 23
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:35am
8-K
EX-99.1
0knvycfwfrzjg1w3mbcx
7 Nov 23
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
8:01am
8-K
EX-99.1
6bwge qy9
2 Nov 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
9gl5pwr1efrymz1jkt
1 Nov 23
BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI
8:35am
8-K
EX-99.1
a3k5yq f5w
24 Aug 23
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
11:25am
8-K
EX-99.1
9km8shs7swb
23 Aug 23
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
8:30am
8-K
EX-99.1
e79kgfj3c7 a8f
22 Aug 23
Latest Software Release Supports Electrophysiologists with Visualizing Heart Patterns Difficult to Recognize with the Naked Eye
8:00am
8-K
EX-1.1
mniy5i8qo79 chlmlj
18 Aug 23
Entry into a Material Definitive Agreement
4:56pm
8-K
EX-99.1
u92xovx38whh jln2
20 Jul 23
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
7:15am
8-K
EX-99.1
qrs4l
27 Jun 23
Regulation FD Disclosure
8:30am